0001493152-26-007122
SEC filingCemtrex, Inc. reported a net loss attributable to stockholders of $20.6 million for Q1 2026, driven by significant interest expense of $12.1 million and an operating loss of $2.8 million. Revenue for the quarter was $16.1 million, generating a gross profit of $5.6 million (gross margin of 34.8%). The company's cash position improved significantly with a net increase in cash, cash equivalents, and restricted cash of $16.2 million, primarily from financing activities that provided $17.3 million in net cash. Total assets stood at $60.3 million with stockholders' equity of $29.1 million. The loss per share from continuing operations was $8.00 (basic and diluted).
Cemtrex, Inc. reported challenging financial results for Q1 2026, with a net loss attributable to stockholders of $20.6 million. Revenue for the quarter was $16.1 million, resulting in a gross profit of $5.6 million. The company experienced an operating loss of $2.8 million, primarily due to high operating expenses of $8.4 million, which included $7.9 million in general and administrative expenses and $501,000 in research and development. Other expenses, particularly interest expense of $12.1 million, contributed significantly to the overall net loss. The loss per share from continuing operations was $8.00 for both basic and diluted calculations.
The filing does not provide segment breakdowns or geographic mix data for revenue. Revenue of $16.1 million generated cost of revenues of $10.5 million, resulting in a gross profit of $5.6 million. No specific growth drivers or product/service breakdowns are disclosed in the provided data. The document focuses on consolidated financial results without segment-level detail.
The company achieved a gross margin of 34.8% ($5.6 million gross profit on $16.1 million revenue). Operating margin was negative at -17.4% due to operating expenses exceeding gross profit. Operating expenses totaled $8.4 million, comprising primarily general and administrative expenses ($7.9 million) and research and development ($501,000). The net loss margin was -127.9% ($20.6 million net loss on $16.1 million revenue), significantly impacted by $12.1 million in interest expense and other non-operating items.
Net cash used in operating activities was $892,000, while investing activities used $253,000. Financing activities provided $17.3 million in net cash, primarily from proceeds on notes payable ($7.0 million), warrant exercises ($5.7 million), and offerings ($6.0 million). The net increase in cash, cash equivalents, and restricted cash was $16.2 million. Total assets were $60.3 million, including $42.7 million in current assets. Total liabilities were $31.2 million, with $18.0 million in current liabilities and $13.3 million in long-term liabilities. Stockholders' equity was $29.1 million, resulting in a debt-to-equity ratio of approximately 1.07.
The filing does not contain management guidance, strategic priorities, or specific risk factor discussions in the provided content. No forward-looking statements or outlook information is included in the extracted financial data sections. The analysis is limited to the historical financial results presented in the 10-Q filing for Q1 2026.